相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models
Erika Calvo-Ochoa et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2015)
Brain metabolic dysfunction at the core of Alzheimer's disease
Suzanne M. de la Monte et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain
Sarah Foerster et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Glucose Regulates Mitochondrial Motility via Milton Modification by O-GlcNAc Transferase
Gulcin Pekkurnaz et al.
CELL (2014)
O-GIcNAc Modification of tau Directly Inhibits Its Aggregation without Perturbing the Conformational Properties of tau Monomers
Scott A. Yuzwa et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
Scott A. Yuzwa et al.
MOLECULAR NEURODEGENERATION (2014)
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
Danielle L. Graham et al.
NEUROPHARMACOLOGY (2014)
Detrimental Effects of Diet-Induced Obesity on τ Pathology Are Independent of Insulin Resistance in τ Transgenic Mice
Antoine Leboucher et al.
DIABETES (2013)
Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400
Andrew Cameron et al.
FEBS LETTERS (2013)
O-linked beta-N-acetylglucosaminidase inhibitor attenuates beta-amyloid plaque and rescues memory impairment
Chaeyoung Kim et al.
NEUROBIOLOGY OF AGING (2013)
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions
Christine M. Burns et al.
NEUROLOGY (2013)
Increasing Brain Protein O-GlcNAc-ylation Mitigates Breathing Defects and Mortality of Tau.P301L Mice
Peter Borghgraef et al.
PLOS ONE (2013)
Insulin signaling, glucose metabolism and mitochondria: Major players in Alzheimer's disease and diabetes interrelation
Sonia C. Correia et al.
BRAIN RESEARCH (2012)
O-GlcNAc processing enzymes: catalytic mechanisms, substrate specificity, and enzyme regulation
David J. Vocadlo
CURRENT OPINION IN CHEMICAL BIOLOGY (2012)
Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
Najla Kfoury et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Global Identification and Characterization of Both O-GlcNAcylation and Phosphorylation at the Murine Synapse
Jonathan C. Trinidad et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis
Mary Katherine Tarrant et al.
NATURE CHEMICAL BIOLOGY (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yang Yu et al.
PLOS ONE (2012)
Developmental Regulation of Protein O-GlcNAcylation, O-GlcNAc Transferase, and O-GlcNAcase in Mammalian Brain
Ying Liu et al.
PLOS ONE (2012)
O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases
Peng Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry
Yuliya V. Skorobogatko et al.
AMINO ACIDS (2011)
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody
Scott A. Yuzwa et al.
AMINO ACIDS (2011)
Longitudinal Change of Biomarkers in Cognitive Decline
Raymond Y. Lo et al.
ARCHIVES OF NEUROLOGY (2011)
Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
Laura D. Baker et al.
ARCHIVES OF NEUROLOGY (2011)
O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
Kristin T. Jacobsen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation
Caroline Smet-Nocca et al.
MOLECULAR BIOSYSTEMS (2011)
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Laurel A. Beckett et al.
ALZHEIMERS & DEMENTIA (2010)
Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase
Matthew S. Macauley et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
Rachel M. Nicholson et al.
BRAIN RESEARCH (2010)
Elevation of Global O-GlcNAc in Rodents Using a Selective O-GlcNAcase Inhibitor Does Not Cause Insulin Resistance or Perturb Glucohomeostasis
Matthew S. Macauley et al.
CHEMISTRY & BIOLOGY (2010)
Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry
Zihao Wang et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model
Carl Julien et al.
NEUROBIOLOGY OF AGING (2010)
Insulin resistance and Alzheimer's disease
Suzanne M. de la Monte
BMB REPORTS (2009)
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Fei Liu et al.
BRAIN (2009)
Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice
Yumiko Uno et al.
BRAIN RESEARCH (2009)
O-GlcNAc Post-Translational Modifications Regulate the Entry of Neurons Into an Axon Branching Program
Herb Francisco et al.
DEVELOPMENTAL NEUROBIOLOGY (2009)
In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation
Melanie K. Tallent et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification
Wagner B. Dias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve
Ann D. Cohen et al.
JOURNAL OF NEUROSCIENCE (2009)
Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
Yazi D. Ke et al.
PLOS ONE (2009)
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Lisa Mosconi et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
Ying Liu et al.
FEBS LETTERS (2008)
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2008)
Cross-talk between GlcNAcylation and phosphorylation:: Site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc
Zihao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Gerald W. Hart et al.
NATURE (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
P. Edison et al.
NEUROLOGY (2007)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry
K Vosseller et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting
X Li et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice
D Terwel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability
N O'Donnell et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress -: A survival response of mammalian cells
NE Zachara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
MAPK recruitment by β-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time
KA Bell et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Amyloid-β deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice
M Sadowski et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism
K Liu et al.
JOURNAL OF NEUROCHEMISTRY (2004)
UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue:: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme
R Okuyama et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex
Y Akimoto et al.
BRAIN RESEARCH (2003)
Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins -: a role in nuclear localization
T Lefebvre et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies - The Honolulu-Asia Aging Study
R Peila et al.
DIABETES (2002)
Cytosolic O-glycosylation is abundant in nerve terminals
RN Cole et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET)
MJ de Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
O-GlcNAc expression in developing and ageing mouse brain
M Rex-Mathes et al.
BIOCHIMIE (2001)
Hippocampal formation glucose metabolism and volume losses in MCI and AD
S De Santi et al.
NEUROBIOLOGY OF AGING (2001)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor β -: Post-translational regulation of turnover and transactivation activity
XG Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Dynamic O-glycosylation of nuclear and cytosolic proteins -: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain
Y Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
分享论文
